Twist Bioscience Corp (NASDAQ:TWST) Q2 2022 Earnings Conference Call May 5, 2022 4:30 PM ET
Company Participants
Angela Bitting - Chief ESG Officer & SVP, Corporate Affairs
Emily Leproust - Co-Founder, Chairman, President & CEO
James Thorburn - CFO
Conference Call Participants
Matthew Sykes - Goldman Sachs Group
Luke Sergott - Barclays Bank
Casey Woodring - JPMorgan Chase & Co.
Matthew Larew - William Blair & Company
Thomas Peterson - Robert W. Baird & Co.
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Twist Biosciences Fiscal 2022 Second Quarter Financial Results Conference Call. [Operator Instructions].
I would now like to turn the call over to your host, Angela Bitting, SVP of Corporate Affairs and Chief ESC Officer.
Angela Bitting
Thank you, operator. Good afternoon, everyone. I would like to thank all of you for joining us today for Twist Biosciences conference call to review our fiscal 2022 second quarter financial results and business progress.
We issued our financial results release this afternoon, which is available at our website at www.twistbioscience.com.
With me on today's call are Dr. Emily Leproust, CEO and Co-Founder of Twist; and Jim Thorburn, CFO of Twist. Emily will begin with a review of our recent progress on Twist businesses. Jim will report on our financial and operational performance. Emily will come back to discuss our upcoming milestones, and directions, and we will then open the call for questions. [Operator Instructions].
As a reminder, this call is being recorded. The audio portion will be archived in the Investors section of our website and will be available for 2 weeks.
During today's presentation, we will make forward-looking statements within the meaning of the U.S. federal securities laws. Forward-looking statements generally relate to future events or future financial or operating performance. Our expectations and beliefs regarding these matters may not materialize, and actual results in financial periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These risks include those set forth in the press release we issued earlier today as well as those more fully described in our filings with the Securities and Exchange Commission.
The forward-looking statements in this presentation are based on information available to us as of the date hereof, and we cannot, at this time, predict the full extent of the ongoing impact of the COVID-19 pandemic and any resulting business or economic impact. We disclaim any obligation to update any forward-looking statements, except as required by law.